Abstract
Memory loss is an abnormal degree of forgetfulness and inability to retrieve past experiences and events. Nootropic agents act on brain to improve the cognitive function. They are used for the treatment of amnesia or dementia, occurring due to the disturbance of neuronal mechanism in various pathological conditions. Long-term potentiation (LTP) is a well-accepted molecular mechanism of learning and memory. Neurotransmitters such as GABA, Nor-epinephrine, dopamine, acetylcholine etc and their receptors are also reported to modulate learning and memory. Impairment in the physiological process of LTP produces memory deficits. Moreover, antioxidant, metabolic enhancers, chelators, nerve growth factors and calcium channel blockers have been reported to decline the progress of neurodegeneration and improve the cognition. Drugs, obtained from various plant sources, are now tested in animals and humans with hope of inventing newer therapeutic agents. doi : 10.5214/ans.0972.7531.2009.160308 Competing interests: None. Source of Funding: None Received Date: 29 May 2009 Revised Date: 24 June 2009 Accepted Date: 11 July 2009
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
